Account
Insider Insights
05.05.2023
HAS issues favorable reimbursement opinion

This is the first time that HAS is issuing a favorable opinion for the reimbursement of a technology...

Read more
Insider Insights
04.05.2023
NICE collaborates with international partner agenc...

UK, Canada and United States join forces to streamline process and increase transparency for confide...

Read more
Insider Insights
28.04.2023
The EU Pharmaceutical package missed the mark in t...

EFPIA and VFA bosses state their concerns that the newly released EU Pharmaceutical Laws will furthe...

Read more
Insider Insights
27.04.2023
The European Commission publish their proposal for...

The European Commission has published their proposal for revised pharmaceutical legislation to cover...

Read more
Insider Insights
25.04.2023
The Nordic Pharmaceutical Forum strengthens its co...

The Nordic Pharmaceutical Forum's new joint strategy focuses on innovative procurement cooperation a...

Read more
Insider Insights
25.04.2023
EU aims to revamp European pharmaceutical laws

With country health budgets drained following the pandemic, the European Commission aims to reform E...

Read more
Insider Insights
22.03.2023
More clarity given on the proposed changes to comb...

The German government has released information regarding the 20% discounts to combination products e...

Read more
Insider Insights
14.03.2023
Newly agreed Windsor Framework carries significant...

Windsor Framework replaces the Northern Ireland protocol to address issues and provide significant c...

Read more
Insider Insights
09.03.2023
What has occurred in the past year in the Swedish ...

TLV unveils annual report, offering insights into trends and projects that have dominated the past y...

Read more
Insider Insights
09.03.2023
Government announces new action plan for rare dise...

Hope that new action plan and collaboration with the rare diseases community will progress positive ...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.